Search Results

There are 11071 results for: content related to: Determinants of sensitivity and resistance to gemcitabine: The roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer

  1. You have free access to this content
    Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma


    Volume 116, Issue 22, 15 November 2010, Pages: 5200–5206, Raphaël Maréchal, John R. Mackey, Raymond Lai, Pieter Demetter, Marc Peeters, Marc Polus, Carol E. Cass, Isabelle Salmon, Jacques Devière and Jean-Luc Van Laethem

    Version of Record online : 3 NOV 2010, DOI: 10.1002/cncr.25303

  2. Efficacy of different chemotherapy regimens in treatment of advanced or metastatic pancreatic cancer: a network meta-analysis

    Journal of Cellular Physiology

    Accepted manuscript online: 19 SEP 2017, Shu-Hua Zhang, Gui-Feng Liu, Xue-Feng Li, Lin Liu and Shao-Nan Yu

    DOI: 10.1002/jcp.26183

  3. You have free access to this content
    Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer


    Volume 116, Issue 22, 15 November 2010, Pages: 5325–5335, Motofumi Tanaka, Milind Javle, Xiaoqun Dong, Cathy Eng, James L. Abbruzzese and Donghui Li

    Version of Record online : 3 NOV 2010, DOI: 10.1002/cncr.25282

  4. Toxicity of Chemotherapy Regimens in Advanced and Metastatic Pancreatic Cancer Therapy: A Network Meta-Analysis

    Journal of Cellular Biochemistry

    Accepted manuscript online: 6 JUL 2017, Xiao-Fang Wang, Wen-Feng Huang, Jian Nie, Yong Zhou, Ding-Wu Tan and Ji-Hao Jiang

    DOI: 10.1002/jcb.26266

  5. You have free access to this content
    Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review

    BJU International

    Volume 109, Issue 4, February 2012, Pages: 496–505, Mike D. Shelley, Gabriel Jones, Anne Cleves, Timothy J. Wilt, Malcolm D. Mason and Howard G. Kynaston

    Version of Record online : 7 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10880.x

  6. You have free access to this content
    Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells

    FEBS Letters

    Volume 579, Issue 29, December 05, 2005, Pages: 6681–6687, Fuminori Teraishi, Lidong Zhang, Wei Guo, Fengqin Dong, John J. Davis, Anning Lin and Bingliang Fang

    Version of Record online : 14 NOV 2005, DOI: 10.1016/j.febslet.2005.10.064

  7. You have free access to this content
    Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells

    The FEBS Journal

    Volume 279, Issue 7, April 2012, Pages: 1261–1273, Fu Li, Gang Hu, Zhenzhou Jiang, Jingjing Guo, Ke Wang, Kedong Ouyang, Danyi Wen, Minghua Zhu, Jiaxin Liang, Xiaoran Qin and Luyong Zhang

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1742-4658.2012.08521.x

  8. HuR's role in gemcitabine efficacy: an exception or opportunity?

    Wiley Interdisciplinary Reviews: RNA

    Volume 2, Issue 3, May/June 2011, Pages: 435–444, Jonathan R. Brody and Gregory E. Gonye

    Version of Record online : 30 NOV 2010, DOI: 10.1002/wrna.62

  9. You have free access to this content
    Synthesis and Biological Evaluation of Oral Prodrugs Based on the Structure of Gemcitabine

    Chemical Biology & Drug Design

    Volume 80, Issue 3, September 2012, Pages: 479–488, Cuirong Zhao, Xiaoxia Xue, Gang Li, Cuicui Sun, Changjun Sun, Xianjun Qu and Wenbao Li

    Version of Record online : 25 JUN 2012, DOI: 10.1111/j.1747-0285.2012.01422.x

  10. You have full text access to this Open Access content
    RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells

    Journal of Cellular and Molecular Medicine

    Volume 12, Issue 6a, December 2008, Pages: 2334–2349, C. Yu, X. Zhang, G. Sun, X. Guo, H. Li, Y. You, J. L. Jacobs, K. Gardner, D. Yuan, Z. Xu, Q. Du, C. Dai, Z. Qian, K. Jiang, Y. Zhu, Q. Q. Li and Y. Miao

    Version of Record online : 6 FEB 2008, DOI: 10.1111/j.1582-4934.2008.00257.x

  11. You have free access to this content
    Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma

    BJU International

    Volume 108, Issue 2, July 2011, Pages: 168–179, Michael D. Shelley, Anne Cleves, Timothy J. Wilt and Malcolm D. Mason

    Version of Record online : 1 JUL 2011, DOI: 10.1111/j.1464-410X.2011.10341.x

  12. You have free access to this content
    Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine

    Human Mutation

    Volume 29, Issue 4, April 2008, Pages: 461–467, Hamdi Jarjanazi, Jeffrey Kiefer, Sevtap Savas, Laurent Briollais, Sukru Tuzmen, Noel Pabalan, Irada Ibrahim-Zada, Spyro Mousses and Hilmi Ozcelik

    Version of Record online : 10 MAR 2008, DOI: 10.1002/humu.20732

  13. Validation of a hydrophilic interaction ultra-performance liquid chromatography–tandem mass spectrometry method for the determination of gemcitabine in human plasma with tetrahydrouridine

    Biomedical Chromatography

    Volume 29, Issue 9, September 2015, Pages: 1343–1349, Yuji Mano, Kenji Sakamaki, Takuya Ueno, Kenji Kita, Takuho Ishii, Koichiro Hotta and Kazutomi Kusano

    Version of Record online : 2 FEB 2015, DOI: 10.1002/bmc.3429

  14. Labeling, biodistribution and evaluation of [125I] gemcitabine: a potential agent for tumor diagnosis and radiotherapy

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 52, Issue 3, March 2009, Pages: 91–97, O. A. El-Kawy, A. M. Hashem, M. A. Amin and A. S. El-Wetery

    Version of Record online : 16 JAN 2009, DOI: 10.1002/jlcr.1573

  15. Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cells

    The Prostate

    Volume 28, Issue 3, March 1996, Pages: 172–181, Marcus V. Cronauer, Helmut Klocker, Heribert Talasz, Francoise H. Geisen, Alfred Hobisch, Christian Radmayr, Günther Böck, Zoran Culig, Michael Schirmer, Andreas Reissigl, Georg Bartsch and Günther Konwalinka

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1097-0045(199603)28:3<172::AID-PROS4>3.0.CO;2-H

  16. You have free access to this content
    Interstitial lung disease associated with gemcitabine: A Japanese retrospective cohort study


    Volume 21, Issue 2, February 2016, Pages: 338–343, Tsuyoshi Hamada, Hideo Yasunaga, Yousuke Nakai, Hiroyuki Isayama, Hiroki Matsui, Kiyohide Fushimi and Kazuhiko Koike

    Version of Record online : 2 NOV 2015, DOI: 10.1111/resp.12665

  17. Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 2, March/April 2006, Pages: 507–514, C.J. POOLE, T. PERREN, S. GAWANDE, M. RIDDERHEIM, J. COOK, A. JENKINS and D. ROYCHOWDHURY

    Version of Record online : 25 APR 2006, DOI: 10.1111/j.1525-1438.2006.00466.x

  18. You have full text access to this OnlineOpen article
    Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer

    Cancer Medicine

    Volume 4, Issue 8, August 2015, Pages: 1224–1239, Neelam V. Desai, Sarunas Sliesoraitis, Steven J. Hughes, Jose G. Trevino, Robert A. Zlotecki, Alison M. Ivey and Thomas J George Jr

    Version of Record online : 13 MAR 2015, DOI: 10.1002/cam4.444

  19. Ceramide metabolism determines glioma cell resistance to chemotherapy

    Journal of Cellular Physiology

    Volume 221, Issue 3, December 2009, Pages: 688–695, Claudia Alexandra Dumitru, Michael Weller and Erich Gulbins

    Version of Record online : 26 AUG 2009, DOI: 10.1002/jcp.21907

  20. Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model

    Radiation Oncology Investigations

    Volume 5, Issue 2, 1997, Pages: 62–71, Marion A. Joschko, Lorraine K. Webster, Janice Groves, Kally Yuen, Manuela Palatsides, David L. Ball and Michael J. Millward

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1520-6823(1997)5:2<62::AID-ROI4>3.0.CO;2-H